Connect Biopharma Limite... (CNTB)
NASDAQ: CNTB
· Real-Time Price · USD
1.54
0.05 (3.36%)
At close: Oct 06, 2025, 1:08 PM
Connect Biopharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Jun 30, 2025 | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Revenue | 1.96M | 26.03M | 24.12M | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 183.53K | 183.53K | 481.87K | 988K | 1.03M | 1.03M | 915.39K | 633.44K | 221.39K |
Gross Profit | 1.78M | 25.37M | 23.16M | -988K | -1.03M | -1.03M | -915.39K | -633.44K | -221.39K |
Operating Income | -38.33M | -17.6M | -19.92M | -62.07M | -89.13M | -117.66M | -121.64M | -99.35M | -41.11M |
Interest Income | 4.65M | 4.85M | -1.67M | 5.2K | 3.79M | 1.56M | 271.15K | 77.81 | 398.24 |
Pretax Income | -35.9M | -15.35M | -21.16M | -59.38M | -87.01M | -116.12M | -116.01M | -202.1M | -145.82M |
Net Income | -36.12M | -15.57M | -21.27M | -59.5M | -87.26M | -116.42M | -116.39M | -202.36M | -145.82M |
Selling & General & Admin | 16.5M | 19.23M | 13.35M | 13.53M | 16.76M | 20.37M | 22.38M | 18.36M | 7.2M |
Research & Development | 24.67M | 29.22M | 38.5M | 51.91M | 71.33M | 95.26M | 97.34M | 80.35M | 33.69M |
Other Expenses | -1.07M | -5M | -8.29M | -4.35M | n/a | -940.31K | -940.31K | n/a | n/a |
Operating Expenses | 40.11M | 43.44M | 44.54M | 62.07M | 88.09M | 114.69M | 118.78M | 98.72M | 40.97M |
Interest Expense | -20K | n/a | 9.61K | n/a | 22.7K | 21.03K | 8.72K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | 5.94M | 13.51M | 16.7M | n/a | 2.04M | 18.35M | 7.19M |
Cost & Expenses | 40.29M | 43.63M | 44.04M | 62.07M | 89.13M | 114.69M | 118.66M | 99.35M | 41.2M |
Income Tax Expense | 217.58K | 222.58K | 115.22K | 120K | 250.95K | 297.52K | 375.21K | 263.87K | n/a |
Shares Outstanding (Basic) | 55.5M | 55.19M | 55.14M | 55.07M | 55.05M | 55.02M | 55.02M | 53.74M | 46.94M |
Shares Outstanding (Diluted) | 55.5M | 55.19M | 55.55M | 55.07M | 55.05M | 55.02M | 55.02M | 53.74M | 46.94M |
EPS (Basic) | -0.65 | -0.28 | -0.38 | -1.08 | -1.59 | -14.5 | -14.52 | -4.15 | -3.1 |
EPS (Diluted) | -0.65 | -0.28 | -0.38 | -1.08 | -1.59 | -14.5 | -14.52 | -4.15 | -3.1 |
EBITDA | -36.12M | -14.68M | -20.18M | -58.37M | -83.76M | -111.31M | -115.4M | -98.72M | -60.4M |
EBIT | -36.48M | -15.34M | -21.14M | -59.36M | -86.99M | -118.04M | -117.95M | -76.96M | -40.23M |
Depreciation & Amortization | 354.53K | 659.53K | 957.87K | 988K | 1.03M | 1.01M | 898.39K | 633.44K | 221.51K |